You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Infliximab biosimilar

Showing 1 - 25 of 553
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hidradenitis Suppurativa Trial in Lahore (Infliximab biosimilar)

Active, not recruiting
  • Hidradenitis Suppurativa
  • Infliximab biosimilar
  • Lahore, Punjab, Pakistan
    Services Institute of Medical Sciences
Dec 22, 2022

Psoriasis Trial in Lahore (Remsima)

Completed
  • Psoriasis
  • Lahore, Punjab, Pakistan
    Ghurki Hospital
Sep 12, 2023

Medicine Called Infliximab[Infliximab Biosimilar 3] in People

Not yet recruiting
  • Arthritis, Rheumatoid
  • +3 more
    • (no location specified)
    Mar 31, 2023

    Ankylosing Spondylitis, Axial Spondyloarthritis Trial (Adalimumab and its biosimilars, Biological: Etanercept and its

    Not yet recruiting
    • Ankylosing Spondylitis
    • Axial Spondyloarthritis
    • Adalimumab and its biosimilars
    • +3 more
    • (no location specified)
    Dec 6, 2021

    Switch From Original Infliximab to Its Biosimilar in Daily

    Completed
    • Rheumatoid Arthritis
    • +3 more
    • Switch from REMICADE® to INFLECTRA®
    • Paris, France
      Hôpital Cochin
    Apr 30, 2021

    Anti-TNFa Treatment Regimes of Hyrimoz or Zessly in Crohn´s

    Completed
    • Crohn´s Disease
      • Innsbruck, Austria
      • +17 more
      Jun 15, 2021

      Crohn's Disease Trial in Seoul (Infliximab-Dyyb)

      Not yet recruiting
      • Crohn's Disease
      • Seoul, Korea, Republic of
        Asan Medical Center
      Oct 5, 2023

      Theranostic Test to PREDict Treatment Response of Anti-TNFa

      Terminated
      • RheumatoId Arthritis
      • Infliximab
      • +6 more
      • Prague, Czechia
      • +7 more
      Dec 21, 2019

      On The Use Of Inflectra™ An Infliximab Biosimilar In Real Life

      Completed
      • Crohn Desease
      • +4 more
      • QOL questionaire
      • Strasbourg, Alsace, France
      • +67 more
      Feb 4, 2022

      IBD Trial in Paris (Biocollection)

      Not yet recruiting
      • Inflammatory Bowel Diseases
      • Biocollection
      • Paris, France
        Saint Antoine Hospital Service de Gastroentérologie et Nutrition
      Feb 1, 2023

      Remsima® (Infliximab) in Rheumatoid Arthritis Patients in Jordan

      Completed
      • Rheumatoid Arthritis
      • Biosimilar Infliximab
      • Amman, Jordan
      • +1 more
      Mar 3, 2020

      Biomarkers to Predict and Monitor Response to Infliximab

      Recruiting
      • Crohn Disease
      • Boston, Massachusetts
        MassGeneral for Children
      Apr 5, 2022

      Crohn Disease, Infliximab, Perianal Fistula Due to Crohn's Disease Trial (TDM-based infliximab intravenous therapy, Standard

      Not yet recruiting
      • Crohn Disease
      • +4 more
      • TDM-based infliximab intravenous therapy
      • Standard infliximab intravenous therapy
      • (no location specified)
      Sep 26, 2023

      EFFICACY AND SAFETY OF S.C. INFLIXIMAB IN PATIENTS SWITCHED FROM

      Recruiting
      • Inflammatory Bowel Diseases
      • Rheumatologic Disease
      • Milano, Italy
        Irccs Ospedale San Raffaele
      Jan 30, 2023

      A 24-month Real Life PErsistence Efficacy and Safety Study in

      Recruiting
      • Inflammatory Bowel Diseases
      • Subcutaneous infliximab CT-P13 Remsima®SC
      • Grenoble, France
        Nicolas Mathieu
      Aug 2, 2022

      Crohn Disease Trial (Azathioprine + infliximab, Intestinal resection)

      Not yet recruiting
      • Crohn Disease
      • Azathioprine + infliximab
      • Intestinal resection
      • (no location specified)
      Oct 14, 2022

      Cytokines and Genes in Therapeutic Response in Crohn's Disease

      Completed
      • Inflammatory Bowel Diseases
      • Baseline blood sample
      • +6 more
      • Nashville, Tennessee
      • +1 more
      May 4, 2022

      Sub-cutaneous Infliximab in Inflammatory Rheumatic Disease

      Not yet recruiting
      • Rheumatoid Arthritis
      • +2 more
      • collection of clinical parameters and blood sample
      • Paris, IDF, France
        Rheumatology Department, Cochin Hospital
      Jun 17, 2022

      Crohn Disease Trial in Cincinnati (RoadMAB)

      Recruiting
      • Crohn Disease
      • RoadMAB
      • Cincinnati, Ohio
        Cincinnati Children's Hospital
      Oct 19, 2021

      Remsima® in Treatment of Inflammatory Bowel Diseases Among Saudi

      Completed
      • Inflammatory Bowel Diseases
      • +3 more
      • Jeddah, Saudi Arabia
      • +3 more
      Feb 22, 2021

      Rheumatoid Arthritis (RA) Trial in Worldwide (NI-071, Infliximab)

      Completed
      Has Results
      • Rheumatoid Arthritis
      • Little Rock, Arkansas
      • +133 more
      Jan 26, 2023

      Arthritis, Rheumatoid Trial in United States (Golimumab Intravenous (IV), Infliximab, Biosimilar Infliximab)

      Completed
      • Arthritis, Rheumatoid
      • Golimumab Intravenous (IV)
      • +2 more
      • Birmingham, Alabama
      • +84 more
      Apr 14, 2020

      Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis Trial in Toulouse (Remsima IV, Remsima SC)

      Recruiting
      • Rheumatoid Arthritis
      • +3 more
      • Remsima IV
      • Remsima SC
      • Toulouse, France
        CHU Purpan Hôpital Pierre Paul Riquet
      May 17, 2023

      Multiple Myeloma, Lymphoma, Engagement, Patient Trial (Grastofil®, Lapelga)

      Not yet recruiting
      • Multiple Myeloma
      • +3 more
      • (no location specified)
      Oct 30, 2023

      Axial Spondyloarthritis Trial (Tapered doses of TNFi, Standard dose of TNFi)

      Recruiting
      • Axial Spondyloarthritis
      • Tapered doses of TNFi
      • Standard dose of TNFi
      • Toronto, Ontario, Canada
        University Health Network - Toronto Western Hospital
      Nov 21, 2022